Health In Tech Inc

Health In Tech Inc (HIT) Stock Analysis

$0.960

-0.020 (-2.04%)At close

Loading chart…
High
0.990
Open
0.980
VWAP
0.97
Vol
46.42K
Mkt Cap
Low
0.960
Amount
45.02K
EV/EBITDA, TTM
-1.99

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.

AI analysis of Health In Tech Inc (HIT)

hold

Health In Tech, Inc. is currently not a good buy due to its declining revenue and negative earnings, despite a potential upside indicated by analyst targets. The current price is $0.98, with a forward P/E of 136.99, suggesting high expectations for future earnings. However, the company has reported a significant year-to-date decline of 44% and a one-year change of -65.97%, indicating ongoing financial struggles. The main risk is the recent revenue decline of 13.5% year-over-year, which raises concerns about its short-term performance.

Valuation Metrics

The current forward P/E ratio for Health In Tech Inc (HIT) is 136.99, compared to its 5-year average forward P/E of 67.73.

Forward P/E

Overvalued
5Y Average P/E
67.73
Current P/E
136.99
Overvalued
123.63
Undervalued
11.82

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.90
Current EV/EBITDA
-1.99
Overvalued
19.37
Undervalued
-5.57

Forward P/S

Fair
5Y Average P/S
1.67
Current P/S
0.90
Overvalued
3.00
Undervalued
0.35

Events Timeline

2026-08-13 (ET)

17:00:00

Company Reports Q2 Revenue of $8.1MM, Exceeding Expectations

17:00:00

Health In Tech Sees 2026 Revenue of $45M-$50M

2026-06-11 (ET)

12:30:00

Health In Tech Files $300M Mixed Securities Shelf

2026-05-13 (ET)

16:10:00

Health In Tech Reports Q1 Revenue of $8.8M, Beating Expectations

16:10:00

Health In Tech Reiterates 2026 Revenue Guidance of $45M to $50M

News

HIT FAQ — answered by Alphio AI

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform. It operates in the Financials sector.

Health In Tech, Inc. is currently not a good buy due to its declining revenue and negative earnings, despite a potential upside indicated by analyst targets. The current price is $0.98, with a forward P/E of 136.99, suggesting high expectations for future earnings. However, the company has reported a significant year-to-date decline of 44% and a one-year change of -65.97%, indicating ongoing financial struggles. The main risk is the recent revenue decline of 13.5% year-over-year, which raises concerns about its short-term performance.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started